Supportivtherapie und Nebenwirkungsmanagement in der Dermatoonkologie

Translated title of the contribution: Supportive therapy and management of side effects in dermato-oncology

Laura von Dücker*, Svea Hüning, Katharina Kähler, Patrick Terheyden, Dorothée Nashan

*Corresponding author for this work


In the context of supportive therapy, possible complaints which may be caused by the cancer itself, by the antitumoral therapy or by psychosocial concerns are considered. Due to the introduction of new anticancer drugs in dermato-oncology, clinicians are confronted with a novel spectrum of adverse events. There are a number of inflammatory, immune-mediated side effects caused by immunotherapies, which can affect virtually any organ. Targeted therapies also have specific side effects. Basically, the management of adverse events depends on their severity. Besides treatment breaks and dosage modifications, immunotherapy-related adverse events are treated with systemic immunosuppressants. Supportive symptomatic therapy is offered. The additional consideration of psychosocial problems can improve quality of life of cancer patients.

Translated title of the contributionSupportive therapy and management of side effects in dermato-oncology
Original languageGerman
Issue number12
Pages (from-to)975-988
Number of pages14
Publication statusPublished - 01.12.2019

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)


Dive into the research topics of 'Supportive therapy and management of side effects in dermato-oncology'. Together they form a unique fingerprint.

Cite this